Rennova Health, Inc. financial data

Symbol
RNVA on OTC
Industry
Services-General Medical & Surgical Hospitals, NEC
Location
400 S. Australian Avenue, Suite 800, West Palm Beach, FL
State of incorporation
DE
Fiscal year end
December 31
Former names
CollabRx, Inc. (to 10/28/2015), TEGAL CORP /DE/ (to 9/25/2012)
Latest financial report
10-Q - Q3 2023 - Nov 14, 2023

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 13.3 % +30.7%
Quick Ratio 0.53 % -7%
Debt-to-equity -174 % -3.2%
Return On Equity 1.18K % +6606%
Return On Assets -1.6K % -6117%
Operating Margin 18 %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 36.3M shares -95.1%
Common Stock, Shares, Outstanding 17.2M shares -96.4%
Entity Public Float 423K USD -94%
Common Stock, Value, Issued 3.71M USD +145%
Weighted Average Number of Shares Outstanding, Basic 4.81M shares +19250916%
Weighted Average Number of Shares Outstanding, Diluted 1.7B shares

Income Statement

Label TTM Value / Value Unit Change %
Revenues 20.3M USD +151%
Revenue from Contract with Customer, Excluding Assessed Tax 20.3M USD +113%
General and Administrative Expense 8.8M USD +50.3%
Costs and Expenses 16.7M USD +13.9%
Operating Income (Loss) 3.65M USD +35%
Nonoperating Income (Expense) -634K USD -322%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 3.01M USD +44.8%
Income Tax Expense (Benefit) -185K USD
Net Income (Loss) Attributable to Parent -329M USD -6466%
Earnings Per Share, Basic 28.8 USD/shares -100%
Earnings Per Share, Diluted 0 USD/shares

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 124K USD +1031%
Accounts Receivable, after Allowance for Credit Loss, Current 1.79M USD -46.2%
Inventory, Net 266K USD -2.81%
Assets, Current 5.68M USD -2.67%
Property, Plant and Equipment, Net 4.27M USD -1.04%
Operating Lease, Right-of-Use Asset 401K USD -37.4%
Intangible Assets, Net (Excluding Goodwill) 259K USD 0%
Assets 19.8M USD -2.18%
Accounts Payable, Current 12.1M USD -2.09%
Employee-related Liabilities, Current 8.53M USD +8.84%
Accrued Liabilities, Current 19.5M USD +0.56%
Liabilities, Current 47.2M USD -5.25%
Operating Lease, Liability, Noncurrent 225K USD -43.9%
Liabilities 47.4M USD -5.56%
Retained Earnings (Accumulated Deficit) -1.7B USD +0.14%
Stockholders' Equity Attributable to Parent -27.6M USD +7.87%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest -27.6M USD +7.84%
Liabilities and Equity 19.8M USD -2.18%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 1.14M USD
Net Cash Provided by (Used in) Financing Activities -855K USD -230%
Net Cash Provided by (Used in) Investing Activities -534K USD -320%
Common Stock, Shares Authorized 250B shares 0%
Common Stock, Shares, Issued 17.2M shares -96.4%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -248K USD +60%
Interest Paid, Excluding Capitalized Interest, Operating Activities 112K USD -85.3%
Deferred Tax Assets, Valuation Allowance 23.8M USD +3.84%
Deferred Tax Assets, Gross 24.4M USD +3.27%
Operating Lease, Liability 401K USD -37.4%
Payments to Acquire Property, Plant, and Equipment 220K USD
Lessee, Operating Lease, Liability, to be Paid 460K USD -40%
Property, Plant and Equipment, Gross 7.04M USD -21.6%
Operating Lease, Liability, Current 176K USD -26.5%
Operating Lease, Weighted Average Discount Rate, Percent 0.13 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 59.3K USD -53.3%
Deferred Tax Assets, Operating Loss Carryforwards 15.4M USD +1.85%
Preferred Stock, Shares Authorized 5M shares 0%
Operating Lease, Payments 82.9K USD +47.5%
Additional Paid in Capital 1.67B USD -0.13%
Depreciation, Depletion and Amortization 368K USD -23.5%
Interest Expense 36.5K USD
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%